Curevo Vaccine Announces Positive Topline Results from
-- Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust immune...
Source: globenewswire.com
Guy De La Rosa News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Guy De La Rosa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Guy De La Rosa Today - Breaking & Trending Today
Enanta Pharmaceuticals, Inc.: Enanta Pharmaceuticals to Present New Data for EDP-235, its 3CL Protease Inhibitor, in Development as an Oral, Once-Daily Treatment for COVID-19, at the 36th International Conference on Antiviral Research
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that data for EDP-235, its lead 3CL
Source: finanznachrichten.de
Enanta Pharmaceuticals to Present New Data for EDP-235, its 3CL Protease Inhibitor, in Development a
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that data for EDP-235, its lead 3CL protease inhibitor in development as an oral, once-daily treatment for COVID-19, w...
Source: pharmiweb.com